These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 501942)

  • 21. Development of sympathetic nervous system in stroke-prone SHR (SHRSP) [proceedings].
    Yamori Y; Akiguchi I; Horie R; Ooshima A; Ohtaka M; Nara Y
    Jpn Heart J; 1979 Sep; 20(5):727. PubMed ID: 501965
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
    Kołodziejczyk J; Wachowicz B
    Pol Merkur Lekarski; 2009 Oct; 27(160):341-5. PubMed ID: 19928667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of acute arterial hypertension in stroke-prone and stroke-resistant SHR.
    Yamori Y; Fujikawa J; Akiguchi I; Nara Y; Ikeda K
    Jpn Heart J; 1978 Jul; 19(4):606-8. PubMed ID: 731899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some studies on plasma renin activity in SHRSP [proceedings].
    Morita N; Okamoto K
    Jpn Heart J; 1977 Jul; 18(4):573-4. PubMed ID: 909185
    [No Abstract]   [Full Text] [Related]  

  • 25. Ophthalmoscopic assessment of functional and organic changes of retinal arteries in stroke-prone SHR (SHRSP) [proceedings].
    Yoshida M; Horie R; Yamori Y; Yoshida H; Ooshima A
    Jpn Heart J; 1979 Sep; 20(5):724. PubMed ID: 501962
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis.
    Catto AJ; Grant PJ
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):497-510. PubMed ID: 7578890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-angiotensin system in severe hypertension of stroke-prone SHR rats.
    Shibota M; Nagaoka A; Shino A; Fujita T
    Jpn Heart J; 1978 Jul; 19(4):655-6. PubMed ID: 731921
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasminogen activators: pharmacology and therapy.
    Holden RW
    Radiology; 1990 Mar; 174(3 Pt 2):993-1001. PubMed ID: 2137641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats (SHR) and SHR stroke-prone.
    Morii N; Nakao K; Kihara M; Sugawara A; Sakamoto M; Yamori Y; Imura H
    Biochem Biophys Res Commun; 1986 Feb; 135(1):74-81. PubMed ID: 2937405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity and molecular weight of renin of plasma and kidney in SHRSP [proceedings].
    Morita N; Okamoto K; Murakami K; Suzuki F; Inagami T
    Jpn Heart J; 1979 Sep; 20(5):704. PubMed ID: 501945
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertensive effects on pregnancy in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP).
    Yamada N; Kido K; Tamai T; Mukai M; Hayashi S
    Int J Biol Res Pregnancy; 1981; 2(2):80-4. PubMed ID: 7333695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of flavone glycosides of Epimedium koreanum on murine fibrinolytic system and apoplectic mortality].
    Shan Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):419-23. PubMed ID: 1303813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
    Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal and abnormal fibrinolysis.
    Kernoff PB; McNicol GP
    Br Med Bull; 1977 Sep; 33(3):239-44. PubMed ID: 143979
    [No Abstract]   [Full Text] [Related]  

  • 36. The molecular weight and character of plasma renin in SHRSP.
    Morita N; Murakami K; Ito H; Okamoto K
    Jpn Heart J; 1978 Jul; 19(4):653-4. PubMed ID: 731920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance vessel structure and function in the etiology of hypertension studied in F2-generation hypertensive-normotensive rats.
    Mulvany MJ
    J Hypertens; 1988 Aug; 6(8):655-63. PubMed ID: 3183371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fibrinolysis modulators].
    Machovich R
    Orv Hetil; 2002 Mar; 143(11):541-5. PubMed ID: 12583322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus anticoagulant and the fibrinolytic system in young patients with stroke.
    Ferro D; Quintarelli C; Rasura M; Antonini G; Violi F
    Stroke; 1993 Mar; 24(3):368-70. PubMed ID: 8446971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis of severe hypertension in stroke-prone SHR (SHRSP)--preliminary report [proceedings].
    Yamori Y; Ikeda K; Ooshima A; Horie R; Nara Y; Ohtaka M
    Jpn Heart J; 1979 Sep; 20(5):710. PubMed ID: 501950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.